tiprankstipranks
Trending News
More News >
BridgeBio Pharma Inc (BBIO)
NASDAQ:BBIO
US Market

BridgeBio Pharma (BBIO) Ownership - Who Owns BridgeBio Pharma?

Compare
1,437 Followers

BridgeBio Pharma (BBIO) Ownership Overview

20.81%21.80%0.07%14.66%42.66%
20.81% Insiders
0.07% Other Institutional Investors
14.66% ETFs
42.66% Public Companies and Individual Investors
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail, and individual investors. Approximately 36.54% of the company’s stock is owned by Institutional Investors, 20.81% is owned by Insiders, and 42.66% is owned by Public Companies and Individual Investors.
The ownership structure of BridgeBio Pharma (BBIO) stock is a mix of institutional, retail, and individual investors. Approximately 21.88% of the company’s stock is owned by Institutional Investors, 20.81% is owned by Insiders, and 14.66% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Nov 19, 2025
xxxxxxxxxxxxx
$6319093
Nov 14, 2025
xxxxxxxxxxxxx
$1683728
Nov 07, 2025
xxxxxxxxxxxxx
$3888895
Sep 08, 2025
xxxxxxxxxxxxx
$3933100

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2025
xxxxxxxxxxxxx
$1057550
Sep 30, 2025
xxxxxxxxxxxxx
$3232953
Sep 30, 2025
xxxxxxxxxxxxx
$10300636
Sep 30, 2025
xxxxxxxxxxxxx
$12098020

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
18,555,375Insider9.63%1,425,795,015
15,977,849Institution8.29%1,227,737,917
15,087,305Institution7.83%1,159,308,516
13,580,329Institution7.05%1,043,512,480
13,260,971Insider6.88%1,018,973,012
8,192,000Institution4.25%629,473,280
7,398,028Institution3.84%568,464,472
6,089,611Institution3.16%467,925,709
5,542,909Insider2.88%425,917,128
2,897,987Institution1.50%222,681,321

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
13,580,329Institution7.05%1,043,512,480
2,897,987Institution1.50%222,681,321
1,702,806Institution0.88%130,843,613
1,531,199Institution0.79%117,657,331
1,529,630Institution0.79%117,536,769
1,206,391Institution0.63%92,699,084
1,034,257Institution0.54%79,472,308
882,788Institution0.46%67,833,430
850,978Institution0.44%65,389,150
822,776Institution0.43%63,222,108

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
5,410,716Institution2.81%389,625,659
4,044,209Institution2.10%291,223,490
3,874,938Institution2.01%297,750,236
2,279,663Institution1.18%164,158,533
1,792,138Institution0.93%129,051,857
1,475,626Institution0.77%113,992,109
1,396,819Institution0.72%107,331,572
1,216,932Institution0.63%93,509,055
814,360Institution0.42%62,909,310
769,993Institution0.40%55,447,196

FAQ

Who Owns BridgeBio Pharma Inc (BBIO)?
According to the latest TipRanks data, approximately 0.07% of the company's stock is held by institutional investors, 20.81% is held by insiders, and 42.66% is held by retail investors.
    What percentage of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.07% of BridgeBio Pharma Inc (BBIO) stock is held by institutional investors.
      What percentage of BridgeBio Pharma Inc (BBIO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 42.66% of BridgeBio Pharma Inc (BBIO) stock is held by retail investors.
        Who owns the most shares of BridgeBio Pharma Inc (BBIO)?
        Viking Global Investors Lp owns the most shares of BridgeBio Pharma Inc (BBIO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.